Mark Bullock

Mark Bullock has a diverse work experience in the pharmaceutical industry. Mark is currently the Global Head Medico and Marketing Strategy Oncology/Haematology at Stemline Therapeutics since February 2021. Prior to this, they worked at Celgene as the Business Unit Director Inflammation and Immunology from June 2018 to February 2021. Mark also held positions at Clovis Oncology as the Senior Director/Head of Commercial (ex USA) from August 2017 to June 2018, at Baxalta as the Business Unit Director from April 2016 to August 2017, and at Novartis in various roles including Global Marketing Director (haematology) and Oncology Marketing Manager (Solid and Rare Tumours) from 2009 to 2016. Before Novartis, they worked at Eli Lilly and Company as the European Marketing Strategy/insight Manager from August 2007 to December 2009 and as a Sales Representative/Key Account Manager from May 2005 to July 2007. Mark began their career at Pfizer as an Executive Hospital Representative from 2001 to 2005.

Mark Bullock attended The University of Salford from 1998 to 2001. However, no information is provided regarding the degree obtained or the field of study pursued during this period.